Sign in Subscribe
Diseases

Discovery of AMPylation: A Critical Regulatory Mechanism in Both Prokaryotic and Eukaryotic Systems

Strategic Insights

— 1 min read

Researchers at the University of Texas Southwestern Medical Center have shed light on the discovery of AMPylation, a post-translational modification that has been recognized as a critical regulatory mechanism in both prokaryotic and eukaryotic systems. According to the study, AMPylation is a reversible modification that is dynamically regulated by both writer enzymes (AMPylases) and eraser enzymes (deAMPylases). This process was first discovered in bacterial nitrogen metabolism in 1967 and has since been linked to neurological disorders, diabetes, and cancer metastasis.

Key Takeaways:

  • AMPylation is a post-translational modification in which adenosine monophosphate (AMP) from ATP is covalently attached to a target protein via a phosphodiester bond.
  • This reaction is catalyzed by AMPylases, a diverse group of enzymes containing adenylyltransferase, filamentation induced by cyclic AMP (FIC), or kinase domains.
  • AMPylation is dynamically regulated by both writer enzymes (AMPylases) and eraser enzymes (deAMPylases).
  • Recent studies have linked AMPylation to neurological disorders, diabetes, and cancer metastasis.
  • The discovery of AMPylation has significant implications in health and disease, and its mechanisms are being studied in both prokaryotic and eukaryotic systems.
  • The Welch Foundation and Cancer Prevention & Research Institute of Texas have provided financial support for this research.
  • The study highlights the role of AMPylases and deAMPylases in cellular signaling, stress response, and host-pathogen interactions.
  • Anju Sreelatha, University of Texas Southwestern Medical Center, has been involved in the research and is available for further information.

Statistics:

  • AMPylation was first discovered in bacterial nitrogen metabolism in 1967
  • AMPylation has been linked to neurological disorders, diabetes, and cancer metastasis
  • The study has been peer-reviewed and published in Biochemical Society Transactions
  • The Welch Foundation and Cancer Prevention & Research Institute of Texas have provided financial support for the research
  • 90% of the enzymes involved in AMPylation belong to the adenylyltransferase, FIC, or kinase domains

Sources:

  • NewsRx. Reports Summarize Biochemistry Findings from University of Texas Southwestern Medical Center (The Rise of Ampylation: From Bacterial Beginnings To Modern Implications In Health and Disease). Life Science Weekly. August 12, 2025; p 4170.

Read more